Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajing Qiu

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Blood Advances|May 20, 2018
The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosisJiajing Qiu, Mohamed E Salama, Cing Siang Hu, et al.
Blood|June 10, 2011
Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cellsChristoph Schaniel, Dario Sirabella, Jiajing Qiu, et al.
Scientific Reports|July 23, 2024
circRNA-0015004 act as a ceRNA to promote RCC2 expression in hepatocellular carcinomaJie Zhao, Tong Zhang, Peng Wu, et al.
Frontiers in Psychology|January 9, 2019
Audio-Visual Spatiotemporal Perceptual Training Enhances the P300 Component in Healthy Older AdultsWeiping Yang, Ao Guo, Yueying Li, et al.
Blood Advances|September 6, 2023
Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesisRaymond Liang, Miao Lin, Vijay Menon, et al.
Blood Advances|September 23, 2018
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cellsXiaoli Wang, Cing Siang Hu, Bruce Petersen, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 28, 2026
Macrophage β-catenin-Ihh axis induces hepatic stellate cell activation and fibrosis in metabolic dysfunction-associated steatohepatitisRongsheng Zhang, Yelin Yang, Feng Xiao, et al.
Blood|September 7, 2014
JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosisXiaoli Wang, Fei Ye, Joseph Tripodi, et al.
Blood|April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cellsXiaoli Wang, David Haylock, Cing Siang Hu, et al.
Cell Death & Disease|February 15, 2024
Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathwayMing Ni, Jiannan Qiu, Guoqing Liu, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Blood Advances|May 20, 2018
The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosisJiajing Qiu, Mohamed E Salama, Cing Siang Hu, et al.
Blood|June 10, 2011
Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cellsChristoph Schaniel, Dario Sirabella, Jiajing Qiu, et al.
Scientific Reports|July 23, 2024
circRNA-0015004 act as a ceRNA to promote RCC2 expression in hepatocellular carcinomaJie Zhao, Tong Zhang, Peng Wu, et al.
Frontiers in Psychology|January 9, 2019
Audio-Visual Spatiotemporal Perceptual Training Enhances the P300 Component in Healthy Older AdultsWeiping Yang, Ao Guo, Yueying Li, et al.
Blood Advances|September 6, 2023
Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesisRaymond Liang, Miao Lin, Vijay Menon, et al.
Blood Advances|September 23, 2018
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cellsXiaoli Wang, Cing Siang Hu, Bruce Petersen, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 28, 2026
Macrophage β-catenin-Ihh axis induces hepatic stellate cell activation and fibrosis in metabolic dysfunction-associated steatohepatitisRongsheng Zhang, Yelin Yang, Feng Xiao, et al.
Blood|September 7, 2014
JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosisXiaoli Wang, Fei Ye, Joseph Tripodi, et al.
Blood|April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cellsXiaoli Wang, David Haylock, Cing Siang Hu, et al.
Cell Death & Disease|February 15, 2024
Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathwayMing Ni, Jiannan Qiu, Guoqing Liu, et al.
Pageof 3